CatalystFDA/Bio

Transgene and Nec Report 100% Three-Year Disease-Free Survival with TG4050 and Publish Phase 1 Results in Nature Communications

100% three-year disease-free survival and Nature Communications publication validate TG4050's efficacy.

What changed

100% three-year disease-free survival and Nature Communications publication validate TG4050's efficacy.

Why it matters

100% three-year disease-free survival and Nature Communications publication validate TG4050's efficacy. — impact context not separately stored; see What changed.

Sources

eodhd